Disclosures for "Acute and Chronic Demyelination Independent of Inflammation Promotes Tissue- and Blood-markers of Neuroaxonal Pathology"
-
The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
-
Dr. Cordano has nothing to disclose.
-
Miss Emberley has nothing to disclose.
-
Dr. Duncan has received research support from National Multiple Sclerosis Society.
-
Dr. Nocera has nothing to disclose.
-
Miss Ananth has nothing to disclose.
-
Ms. Jabassini has nothing to disclose.
-
Ms. Ning has nothing to disclose.
-
Ms. Reinsberg has nothing to disclose.
-
The institution of Dr. Oertel has received research support from AAN. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
-
Ms. Beaudry-richard has nothing to disclose.
-
Dr. Kuhle has nothing to disclose.
-
Dr. Watkins has stock in Aravive, Inc. The institution of Dr. Watkins has received research support from TIRR Foundation Mission Connect.
-
Jonah Chan, PhD has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pipeline Therapeutics. Jonah Chan, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SFN. Jonah Chan, PhD has stock in Pipeline Therapeutics. The institution of Jonah Chan, PhD has received research support from Mead Johnson. Jonah Chan, PhD has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH/NINDS.
-
Dr. Emery has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Autobahn Therapeutics. Dr. Emery has stock in Autobahn Therapeutics.
-
Dr. Green has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline Therapeutics. Dr. Green has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from NINDS. The institution of Dr. Green has received research support from NMSS. The institution of Dr. Green has received research support from NIA. The institution of Dr. Green has received research support from Adelson Research Foundation. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. Dr. Green has received personal compensation in the range of $500-$4,999 for serving as a Study Section with NINDS. Dr. Green has a non-compensated relationship as a Author with Viela Bio that is relevant to AAN interests or activities.